ELISA for the neuropeptide degrading endopeptidase 3.4.24.11 in human serum and leukocytes.
We describe the development of a new ELISA for the detection of neural endopeptidase 3.4.24.11 (NEP). Neutral endopeptidase 3.4.24.11 was determined in preparations of human granulocytes, mononuclear cells (MNC), and in serum. Human recombinant NEP was used as reference. Specificity of the mAbs was tested using APAAP, FACS analysis, and Western blot analysis. Lysis of the blood cells was performed by incubating the cells with 0.4% Tween-20 and repeated freezing cycles. The minimal detectable dose for recombinant NEP was 15 pg/ml. The recovery was 94 +/- 9%. The NEP was detectable in 15 out of 20 serum samples of 20 volunteers (mean +/- SEM, 245 +/- 88 pg/ml, n = 20)) and in all granulocyte preparations (1176 +/- 138 pg/10(7) cells, n = 20)). The results were reproducible among replicates (CV = 3 +/- 1%, n = 40), dilutions (CV = 8 +/- 2%, n = 5), and assays (CV = 12 +/- 4%, n = 5). With this new ELISA, a simple and reproducible method for the measurement of NEP 3.4.24.11 is described.
Zhang
M
M
Department of Clinical Immunology and Asthma-OPD, Free University Berlin, Germany.
Niehus
J
J
Schnellbacher
T
T
Müller
S
S
Graf
K
K
Schultz
K D
KD
Baumgarten
C R
CR
Lucas
C
C
Kunkel
G
G
D015153:Blotting, Western; D002469:Cell Separation; D004797:Enzyme-Linked Immunosorbent Assay; D005434:Flow Cytometry; D006801:Humans; D007962:Leukocytes / Q000201:enzymology*; D015260:Neprilysin / Q000097:blood*; D013194:Staining and Labeling
D015260:Neprilysin